In vivo and in vitro investigations on biological effects of aromatic bis-(2-chloroethyl)amino-bisphosphonic acids, new agents proposed for chemotherapy of bone tumors: cytostatic activity in rat osteosarcoma; toxicity and genotoxicity in liver and bone marrow; mutagenicity in S. Typhimurium Beatrice L. PoolMartin BergerFranz Wingen Preclinical Studies Pages: 67 - 78
In vitro activity of amonafide against primary human tumors compared with the activity of standard agents Jaffer A. AjaniFraser L. BakerGary Spitzer Preclinical Studies Pages: 79 - 85
Clinical trial of iproplatin (cis-dichloro-trans-dihydroxy-bis-isopropylamine platinum IV, CHIP) in patients with advanced breast cancer Ephraim S. CasperTracy C. SmartRichard J. Kaufman Clinical Studies Pages: 87 - 91
PCNU: Phase II evaluation in advanced colorectal carcinoma Richard PazdurMichael K. SamsonLaurence H. Baker Clinical Studies Pages: 93 - 95
Phase II trials of 5-day vinblastine infusion (NSC 49842), L-alanosine (NSC 153353), acivicin (NSC 163501), and aminothiadiazole (NSC 4728) in patients with recurrent or metastatic renal cell carcinoma Paul J. ElsonLarry K. KvolsThomas E. Davis Clinical Studies Pages: 97 - 103
Mitoxantrone in combination with prednimustine in treatment of unfavorable non-Hodgkin lymphoma Karl E. Landys Clinical Studies Pages: 105 - 113
Human leukocyte alpha interferon-induced transient neurotoxicity in children Julie A. KatzDonald H. MahoneyDonald J. Fernbach Clinical Studies Pages: 115 - 120
Acute leukemia occurring after radiotherapy and chemotherapy with a nitrosourea, PCNU Kirk V. ShepardRichard LarsonBernard Levin Clinical Studies Pages: 121 - 124
Alterations in human circulating and bone marrow mononuclear cell polyamine levels in hematologic malignancies as a consequence of difluoromethylornithine administration Anne-Marie MaddoxEmil J. FreireichMari K. Haddox Clinical Studies Pages: 125 - 134
Evolution of high-dose cisplatin Walter M. HolleranMichael W. DeGregorio Clinical Studies Pages: 135 - 142
